Being immunocompromised makes CLL patients one of the most vulnerable patient groups
Clinical haematologist and researcher, Associate Professor Nada Hamad discusses the latest on CLL.
- Chronic lymphocytic leukaemia
- Treatments and side-effects
Tag: Treatments and side-effects
Don had a stem cell transplant at 70 and says “exercise helped”
Don Hayes had an allogeneic stem cell transplant days before his 71st birthday.
- Myelodysplastic syndromes
- Research
- Treatments and side-effects
PBAC considering selinexor for a third time
For the third time, selinexor (Xpovio®) will be considered by the Pharmaceutical Benefits Advisory Committee (PBAC) at its November 2022 meeting for the treatment of relapsed/refractory (R/R) myeloma.
- Myeloma
- Treatments and side-effects
PBAC recommends daratumumab for newly diagnosed AL amyloidosis
Daratumumab (Darzalex®) could be the first ever therapy to be approved in Australia for AL amyloidosis.
- Amyloidosis
- Treatments and side-effects
New targeted treatment option available for Waldenström macroglobulinemia (WM) patients through PBS.
The Leukaemia Foundation has welcomed news that for the first time, a targeted treatment option will now be available for Waldenström macroglobulinemia (WM) patients through the Pharmaceutical Benefits Scheme (PBS).
- Other blood cancers
- Treatments and side-effects
Patients retain remission for 10+ years after CAR T-cell therapy
It’s 10 years since the first CLL patients were treated with CAR T-cell therapy and they are still in remission.
- Chronic lymphocytic leukaemia
- Treatments and side-effects
Jane’s had three different cancer diagnoses in two years
- Acute myeloid leukaemia
- Myelodysplastic syndromes
- Treatments and side-effects
Expert Series: Prof. John Pimanda – lots of work is needed to improve long-term outcomes for MDS
- Interviews with experts
- Myelodysplastic syndromes
- Treatments and side-effects
Katrina’s five-year delay in diagnosis was followed by a further wait for access to treatment.
- Treatments and side-effects
Support for submission to MSAC for MRD testing reimbursement in ALL
- Acute lymphoblastic leukaemia
- Treatments and side-effects
